Y. H. Hidayat, H. Ishardyanto, and L. Anniwati, “High Sensitive Troponin I and Extended Range C-Reactive Protein as Markers to Predict Cardiotoxicity in Locally Advanced Breast Cancer with Neoadjuvant CAF (Cyclophoshpamide, Adriamycin/Doxorubicin, 5Fluorouracil) Therapy”, FMI, vol. 56, no. 2, pp. 91–98, Jun. 2020.